Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
The Company is committed to continuing its development as a niche oncology product company. The relatively shorter development time for its niche product candidates, e.g. SaveneTM and SavicolTM, will, if approved for commercialisation, allow TopoTarget to establish relationships with oncology clinics and to build European sales and marketing capabilities at an early stage. This potential early entry of niche products on the market is expected to facilitate any future introductions of other product candidates. To expedite development of product candidates with potential broad applications, TopoTarget will seek collaborations with partners to assist in clinical matters, such as in patient recruitment, and in commercial matters, such as in providing geographic ( www.topotarget.com )
TopoTarget
87A Milton Park
Abingdon, Oxfordshire OX14 4RY
United Kingdom
Tel: +44 1235 443 700
Fax: +44 1235 835 557